Colgate-Palmolive (CL) Stock Forecast & Price Target

$103.79

+0.48 (+0.46%)

(As of 09/24/2024 ET)

Colgate-Palmolive - Analysts' Recommendations and Stock Price Forecast (2024)

MarketBeat calculates consensus analyst ratings for stocks using the most recent rating from each Wall Street analyst that has rated a stock within the last twelve months. Each analyst's rating is normalized to a standardized rating score of 1 (sell), 2 (hold), 3 (buy) or 4 (strong buy). Analyst consensus ratings scores are calculated using the mean average of the number of normalized sell, hold, buy and strong buy ratings from Wall Street analysts. Each stock's consensus analyst rating is derived from its calculated consensus ratings score (0 to .5 = Strong Sell, .5 to 1 = Sell, 1 to 1.5 = Reduce, 1.5 to 2.5 = Hold, 2.5 to 3.0 = Moderate Buy, 3.0 to 3.5 = Buy, >3.5 = Strong Buy). MarketBeat's consensus price targets are a mean average of the most recent available price targets set by each analyst that has set a price target for the stock in the last twelve months. MarketBeat's consensus ratings and consensus price targets may differ from those calculated by other firms due to differences in methodology and available data.

Consensus Rating

Moderate Buy
Based on 22 Analyst Ratings

Sell
1

Hold
8

Buy
13

Based on 22 Wall Street analysts who have issued ratings for Colgate-Palmolive in the last 12 months, the stock has a consensus rating of "Moderate Buy." Out of the 22 analysts, 1 has given a sell rating, 8 have given a hold rating, and 13 have given a buy rating for CL.

Consensus Price Target

$104.74
0.91% Upside

According to the 22 analysts' twelve-month price targets for Colgate-Palmolive, the average price target is $104.74. The highest price target for CL is $122.00, while the lowest price target for CL is $90.00. The average price target represents a forecasted upside of 0.91% from the current price of $103.79.

Get the Latest News and Ratings for CL and Related Stocks

Enter your email address to receive the latest news and analysts' ratings for Colgate-Palmolive and its competitors.

CL Analyst Ratings Over Time

Type	Current Forecast 9/26/23 to 9/25/24	1 Month Ago 8/27/23 to 8/26/24	3 Months Ago 6/28/23 to 6/27/24	1 Year Ago 9/26/22 to 9/26/23
Strong Buy	0 Strong Buy rating(s)	0 Strong Buy rating(s)	0 Strong Buy rating(s)	0 Strong Buy rating(s)
Buy	13 Buy rating(s)	13 Buy rating(s)	14 Buy rating(s)	8 Buy rating(s)
Hold	8 Hold rating(s)	8 Hold rating(s)	3 Hold rating(s)	4 Hold rating(s)
Sell	1 Sell rating(s)	0 Sell rating(s)	0 Sell rating(s)	0 Sell rating(s)
Consensus Price Target	$104.74	$101.11	$93.83	$85.23
Forecasted Upside	0.91% Upside	-3.79% Downside	-4.42% Downside	18.38% Upside
Consensus Rating	Moderate Buy	Moderate Buy	Moderate Buy	Moderate Buy

Elon Musk’s chilling warning for humanity (Ad)

The 'invasion' I've discovered has nothing to do with the border crisis. What's happening at our southern border is a travesty, but the 'invasion' I've found will have 10 times greater effects on our economy, and ultimately our way of life.

Go here to see why.

CL Analyst Recommendations By Month

The chart below shows how a company's ratings by analysts have changed over time. Each bar represents the previous year of ratings for that month. Within each bar, the sell ratings are shown in red, the hold ratings are shown in yellow, the buy ratings are shown in green, and the strong buy ratings are shown in dark green.

CL Price Targets by Month

The chart below shows how a company's share price and consensus price target have changed over time. The dark blue line represents the company's actual price. The lighter blue line represents the stock's consensus price target. The even lighter blue range in the background of the two lines represents the low price target and the high price target for each stock.

Colgate-Palmolive Stock vs. The Competition

Type	Colgate-Palmolive	Consumer Staples Companies	S&P 500
Consensus Rating Score	2.55	2.45	2.50
Consensus Rating	Moderate Buy	Hold	Hold
Predicted Upside	0.91% Upside	629.59% Upside	6.80% Upside
News Sentiment Rating	Positive News See Recent CL News	Positive News	Positive News

Recent Analyst Forecasts and Stock Ratings

Rating

Upside/Downside

Action

Time Frame

Start Date

End Date

Show

Export to Excel

Date	Brokerage	Analyst Name	Action	Rating	Price Target	Upside/Downside on Report Date
9/24/2024	Piper Sandler 2 of 5 stars		Initiated Coverage	Overweight	$121.00	+17.12%
9/16/2024	Wells Fargo & Company 3 of 5 stars	C. Carey Subscribe to MarketBeat All Access for the recommendation accuracy rating	Downgrade	Equal Weight ➝ Underweight	$100.00	-5.42%
9/9/2024	Deutsche Bank Aktiengesellschaft 2 of 5 stars		Downgrade	Buy ➝ Hold	$107.00 ➝ $109.00	+1.06%
9/4/2024	UBS Group Subscribe to MarketBeat All Access for the recommendation accuracy rating		Boost Target	Buy ➝ Buy	$119.00 ➝ $122.00	+11.95%
8/1/2024	Redburn Atlantic Subscribe to MarketBeat All Access for the recommendation accuracy rating	E. Lewis Subscribe to MarketBeat All Access for the recommendation accuracy rating	Upgrade	Hold
7/30/2024	TD Cowen Subscribe to MarketBeat All Access for the recommendation accuracy rating	R. Moskow Subscribe to MarketBeat All Access for the recommendation accuracy rating	Boost Target	Buy ➝ Buy	$110.00 ➝ $115.00	+14.97%
Get the Latest News and Ratings for CL and Related Stocks Enter your email address below to receive the latest news and analysts' ratings for Colgate-Palmolive and its competitors with MarketBeat's FREE daily newsletter.
7/30/2024	Sanford C. Bernstein Subscribe to MarketBeat All Access for the recommendation accuracy rating		Boost Target	Market Perform ➝ Market Perform	$100.00 ➝ $103.00	+3.00%
7/29/2024	Morgan Stanley Subscribe to MarketBeat All Access for the recommendation accuracy rating		Boost Target	Overweight ➝ Overweight	$103.00 ➝ $111.00	+10.46%
7/29/2024	Barclays Subscribe to MarketBeat All Access for the recommendation accuracy rating		Boost Target	Equal Weight ➝ Equal Weight	$91.00 ➝ $96.00	-4.61%
7/26/2024	Hsbc Global Res Subscribe to MarketBeat All Access for the recommendation accuracy rating	A. Zamacona Subscribe to MarketBeat All Access for the recommendation accuracy rating	Downgrade	Strong-Buy ➝ Hold
7/26/2024	HSBC Subscribe to MarketBeat All Access for the recommendation accuracy rating		Reiterated Rating	Buy ➝ Hold
7/24/2024	Jefferies Financial Group Subscribe to MarketBeat All Access for the recommendation accuracy rating		Downgrade	Buy ➝ Hold	$103.00 ➝ $95.00	-1.61%
7/22/2024	Stifel Nicolaus Subscribe to MarketBeat All Access for the recommendation accuracy rating		Boost Target	Buy ➝ Buy	$95.00 ➝ $105.00	+7.06%
7/18/2024	Evercore ISI Subscribe to MarketBeat All Access for the recommendation accuracy rating		Boost Target	Outperform ➝ Outperform	$100.00 ➝ $106.00	+6.91%
7/10/2024	Citigroup Subscribe to MarketBeat All Access for the recommendation accuracy rating		Boost Target	Buy ➝ Buy	$103.00 ➝ $112.00	+15.00%
7/10/2024	Bank of America Subscribe to MarketBeat All Access for the recommendation accuracy rating		Boost Target	Buy ➝ Buy	$100.00 ➝ $110.00	+13.26%
6/24/2024	BNP Paribas Subscribe to MarketBeat All Access for the recommendation accuracy rating	K. Grundy Subscribe to MarketBeat All Access for the recommendation accuracy rating	Initiated Coverage	Outperform	$109.00	+12.06%
5/15/2024	Argus Subscribe to MarketBeat All Access for the recommendation accuracy rating	C. Graja Subscribe to MarketBeat All Access for the recommendation accuracy rating	Boost Target	Buy ➝ Buy	$97.00 ➝ $107.00	+13.01%
4/29/2024	Royal Bank of Canada Subscribe to MarketBeat All Access for the recommendation accuracy rating		Boost Target	Sector Perform ➝ Sector Perform	$88.00 ➝ $95.00	+4.38%
3/1/2024	The Goldman Sachs Group Subscribe to MarketBeat All Access for the recommendation accuracy rating		Initiated Coverage	Buy	$93.00	+7.50%
1/29/2024	Raymond James Subscribe to MarketBeat All Access for the recommendation accuracy rating		Upgrade	Market Perform ➝ Outperform	$91.00	+9.86%
1/18/2024	JPMorgan Chase & Co. Subscribe to MarketBeat All Access for the recommendation accuracy rating		Boost Target	Overweight ➝ Overweight	$88.00 ➝ $90.00	+11.55%
11/21/2022	Wolfe Research Subscribe to MarketBeat All Access for the recommendation accuracy rating		Initiated Coverage	Market Perform
10/18/2022	Credit Suisse Group Subscribe to MarketBeat All Access for the recommendation accuracy rating		Lower Target	Outperform	$88.00 ➝ $85.00	+17.83%

Analyst ratings data on MarketBeat is provided by Benzinga and other data providers. This page was last refreshed on Wednesday at 06:20 AM ET.

Should I Buy Colgate-Palmolive Stock? CL Pros and Cons Explained

These pros and cons were generated based on recent news and financial data from MarketBeat in order to provide readers with the fastest and most accurate insights. They were last updated on Saturday, September 21, 2024. Please send any questions or comments about these Colgate-Palmolive pros and cons to contact@marketbeat.com.

Colgate-Palmolive
Bull Case

Here are some ways that investors could benefit from investing in Colgate-Palmolive:

Colgate-Palmolive stock has shown consistent growth potential, with Wall Street analysts forecasting positive growth and target price increases.
Insider selling activity could indicate confidence in the company's performance and future prospects, as insiders typically have in-depth knowledge of the company's operations.
Colgate-Palmolive's stock price has been trending upwards, reaching a recent high of $109.30, indicating positive market sentiment towards the company.
Strong brand recognition and global presence of Colgate-Palmolive's products provide stability and potential for continued revenue growth.
Positive analyst ratings and consensus price targets suggest a favorable outlook for Colgate-Palmolive's stock performance.

Colgate-Palmolive
Bear Case

Investors should be bearish about investing in Colgate-Palmolive for these reasons:

Recent insider selling activity, although it could indicate confidence, may also raise concerns about potential future performance or market conditions.
Colgate-Palmolive's stock price has experienced fluctuations, which could introduce volatility and uncertainty for investors.
Market conditions and economic factors could impact consumer spending on personal care products, affecting Colgate-Palmolive's revenue and profitability.
Debt-to-equity ratio of 16.90 may raise concerns about the company's financial leverage and ability to manage debt obligations effectively.
Price-to-earnings ratio of 32.41 and price-to-earnings-growth ratio of 3.72 may indicate that the stock is relatively expensive compared to its earnings and growth potential.

CL Forecast - Frequently Asked Questions

: According to the research reports of 22 Wall Street equities research analysts, the average twelve-month stock price forecast for Colgate-Palmolive is $104.74, with a high forecast of $122.00 and a low forecast of $90.00.
: 22 Wall Street research analysts have issued "buy," "hold," and "sell" ratings for Colgate-Palmolive in the last twelve months. There is currently 1 sell rating, 8 hold ratings and 13 buy ratings for the stock. The consensus among Wall Street research analysts is that investors should "moderate buy" CL shares.
: According to analysts, Colgate-Palmolive's stock has a predicted upside of 0.91% based on their 12-month stock forecasts.
: Over the previous 90 days, Colgate-Palmolive's stock had 4 downgrades and 1 upgrade by analysts.
: Colgate-Palmolive has been rated by research analysts at Bank of America, Barclays, Citigroup, Deutsche Bank Aktiengesellschaft, Evercore ISI, Hsbc Global Res, HSBC, Jefferies Financial Group, Morgan Stanley, Piper Sandler, Redburn Atlantic, Sanford C. Bernstein, Stifel Nicolaus, TD Cowen, UBS Group, and Wells Fargo & Company in the past 90 days.
: Analysts like Colgate-Palmolive more than other "consumer staples" companies. The consensus rating for Colgate-Palmolive is Moderate Buy while the average consensus rating for "consumer staples" companies is Hold. Learn more on how CL compares to other companies.